U.S. Sens. Chuck Grassley, R-Iowa, and Amy Klobuchar, D-Minnesota, say they have new confidence Congress will continue efforts to lower prescription drug costs.
Articles Tagged: Prescription drug pricing
Campaigns & Elections Oct. 10, 2022 8:56 am1107d ago
A state lawmaker, children’s advocate, wife and mother, Democrat Liz Mathis said she has a track record of putting Iowans first and working across the aisle.
Government & Politics Aug. 18, 2022 7:00 pm1160d ago
Cedar Rapids panelists discuss impact of Inflation Reduction Act
Government & Politics Aug. 14, 2022 6:00 am1164d ago
Insulin has become the poster-child drug when it comes to the debate over controlling skyrocketing drug prices and life-or-death stakes.
Government & Politics Aug. 7, 2022 8:30 pm1171d ago
Democratic U.S. Senate candidate Mike Franken took Iowa Republican U.S. Sen. Chuck Grassley to task over efforts to lower prescription drug prices for Iowans.
Gazette Des Moines Bureau
News Jun. 25, 2022 6:00 am1214d ago
Recap of news from across the state
State Government Jun. 19, 2022 6:00 am1220d ago
The law addresses pharmacy benefits managers, which are middle men between pharmacies and insurance companies.
State Government Jun. 14, 2022 8:35 am1225d ago
Measures include pharmacy benefits managers, child care costs
Campaigns & Elections Apr. 1, 2022 10:16 pm1299d ago
Public opinion polls have consistently shown support across party lines for capping the monthly cost of insulin. However, experts say the House bill would not help uninsured people, who face the highest out-of-pocket costs for insulin.
Government & Politics Jan. 19, 2022 4:03 pm1371d ago
The Iowa Republican, who a year ago saw opportunities to work with his former Senate colleague on issues such as prescription drug pricing, now believes the president’s compromises to appease progressives are limiting his ability to reach bipartisan agreement on his proposals.
Government & Politics Nov. 29, 2021 9:59 am1422d ago
In a TV ad airing in Cedar Rapids and across the U.S., a pharmaceutical trade organization claims that proposed legislation to allow the federal government to negotiate with pharmaceutical companies on the cost of drugs would mean Medicare patients won’t be able to access the medications they need. But is that true?